Yi Peng
Sun Yat-sen University
6 Papers
13 Citations
Yi Peng is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: ELISPOT & Biology. The author has an hindex of 4, co-authored 5 publications.
Chat about Author
Papers
Antimycobacterial activity of fusaric acid from a mangrove endophyte and its metal complexes.
Jia-Hui Pan,Yi Chen,Yuhong Huang,Yi-Wen Tao,Jun Wang,Yan Li,Yi Peng,Tao Dong,Xiaomin Lai,Yongcheng Lin +9 more
TL;DR: This is the first report of the antimycobacterial activity of the mangrove Fusarium metabolite and its coordinating metal complexes.
43
Use of HLA-DR*08032/E7 and HLA-DR*0818/E7 tetramers in tracking of epitope-specific CD4+ T cells in active and convalescent tuberculosis patients compared with control donors.
Yan Li,Yan Zhu,Lin Zhou,Yimin Fang,Lirong Huang,Liangliang Ren,Yi Peng,Yifen Li,Fangfang Yang,Dan Xie,Wenzheng Tang,Na Zhang,Qiu Zhong,Xiaomin Lai +13 more
TL;DR: By further increasing the sample size tested to confirm the specificity and sensitivity of tetrameric molecules, it should be possible to develop them for use as research and diagnostic reagents.
14
Interferon-gamma ELISPOT for the screening and diagnosis of latent tuberculosis infection in healthy population of China *
Yi Peng,Fangfang Yang,Lin Zhou,Meigui Zhao,Yan Li,Yuhong Huang,Juan Wang,Lirong Huang,Dan Xie,Zhi-Quan Tu,Weiling Lin,Jinhong Liu,Qiu Zhong,Xiaomin Lai +13 more
TL;DR: It can be seen that the three kinds of in-house IFN-γ ELIS- POT might be used as a complementary tool of T- SPOT.TB for detecting LTBI in the healthy population of China.
Anti-mycobacterial activity of marine fungus-derived 4-deoxybostrycin and nigrosporin.
Cong Wang,Juan Wang,Yuhong Huang,Hong Chen,Yan Li,Lili Zhong,Yi Chen,Shengping Chen,Jun Wang,Juling Kang,Yi Peng,Bin Yang,Yongcheng Lin,Zhigang She,Xiaomin Lai +14 more
TL;DR: The present study provides a useful experiment basis for exploitation of correlative new drugs against TB and for finding out new targets of anti-mycobacterial therapy.
Development of Receptor Binding Domain (RBD)‐Conjugated Nanoparticle Vaccines with Broad Neutralization against SARS‐CoV‐2 Delta and Other Variants
Ran Chen,Xiantao Zhang,Yaochang Yuan,Xiao Jie Deng,Bolin Wu,Zhihui Xi,Guanwen Wang,Yingtong Lin,Rong Li,Xuemei Wang,Fan Zou,Liting Liang,Haiping Yan,Chaofeng Liang,Yuzhuang Li,S. Wu,Jieyi Deng,Mo Zhou,Xu Zhang,Congrong Li,Xiuqing Bu,Yi Peng,Changwen Ke,Kai Deng,Xin He,Yiwen Zhang,Zhenhai Zhang,Ting Pan,Hui Zhang +28 more
TL;DR: It is suggested that RBD‐based monovalent or multivalent nanoparticle vaccines provide a promising second‐generation vaccine strategy for SARS‐CoV‐2 variants.